We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.


The West Blog

Latest Post

December 11, 2018

Container Closure Integrity at Low Temperatures

With the help of the FDA’s expedited programs for approval, a new wave of high-value biologic drugs is on the rise in the pharma industry.1 These drugs require cryogenic storage (-80oC to -180oC) to maintain stability. This presents a new challenge: how to measure and demonstrate container closure integrity (CCI) of storage and delivery systems at such low temperatures.</br>
West Pharma

Amy Kim

Specialist, Scientific Communications, TCS

Subscribe to receive the latest blog post
Previous Posts
Load more